Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)

Chong Kun Dang Pharmaceutical Revenue

Chong Kun Dang Pharmaceutical had revenue of 396.80B KRW in the quarter ending June 30, 2024, with 0.20% growth. This brings the company's revenue in the last twelve months to 1.67T, up 8.07% year-over-year. In the year 2023, Chong Kun Dang Pharmaceutical had annual revenue of 1.67T with 12.17% growth.

• Revenue (ttm): 1,666.52B
• Revenue Growth: +8.07%
• P/S Ratio: 0.74
• Revenue / Employee: 729.01M
• Employees: 2,286
• Market Cap: 1,225.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1,669.40B	181.06B	12.17%
Dec 31, 2022	1,488.34B	144.79B	10.78%
Dec 31, 2021	1,343.56B	40.55B	3.11%
Dec 31, 2020	1,303.01B	223.67B	20.72%
Dec 31, 2019	1,079.34B	123.12B	12.88%